Surprise medical billing is shown to drive up premiums for everyone; a new report shows how much more we’re paying for drugs in the U.S.; the rising cost of care is linked to health system consolidation; and, stakeholders bridge the critical gaps in maternal health.
A relatively small number of drugs are found to drive up Medicare drug spending; stakeholders urge Congress to repeal the harmful rebate rule; payers operationalize resources for the ongoing special enrollment period on the exchanges; and, our definition of social determinants of health expands to better account for drivers of poor health outcomes.
A new analysis undermines one of Big Pharma’s biggest justifications; ER docs surprise bill patients as much as ten times more; lawmakers work to advance an important audio-only telehealth proposal; and, stakeholders focus on the importance of population health.
COVID-related hospitalizations cost the Medicare program more than $10 billion last year; facility fees present the latest front in the effort to combat surprise medical billing; meanwhile, pandemic strain on smaller physician offices is paving the way for increased consolidation; and, hospital mergers are shown to significantly slow wage growth.
COVID-related hospitalizations cost the Medicare program more than $10 billion last year; facility fees present the latest front in the effort to combat surprise medical billing; meanwhile, pandemic strain on smaller physician offices is paving the way for increased consolidation; and, hospital mergers are shown to significantly slow wage growth.
Stakeholders collaborate on vaccine distribution and access; meanwhile, the pandemic takes a toll on mental health; hospitals face a reckoning over healthcare disparities; and, Medicaid managed care plans help address inequities.
Hard-learned lessons one year into the coronavirus pandemic, including a worsening of the loneliness epidemic; stakeholders continue to point out why the rebate rule is the wrong prescription for combatting high drug prices; and, a reminder of where our healthcare spending goes.
New analyses highlight the potential savings offered by generic drugs; experts consider what telehealth might look like on the other side of the pandemic; the growing role of AI in our healthcare future; and, a recent survey of employers points to the growing importance of integrated benefits.
Stakeholders continue to focus on the harms of the rebate rule; provider consolidation goes under the microscope; hospital billing practices suggest Medicare upcoding; and, Medicaid can help better address social health drivers.
Lawmakers convene a hearing on vaccines; private equity exacts a terrible toll on nursing home populations; Medicaid expansion led to fewer uninsured young adults; and, a handful of chronic conditions cost employers billions of dollars.